Elicio Therapeutics, Inc. Quarterly Operating Margin in % from Q4 2020 to Q1 2023

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Elicio Therapeutics, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2020 to Q1 2023.
  • Elicio Therapeutics, Inc. Operating Margin for the quarter ending March 31, 2023 was -2.61K %, a 2183% decline year-over-year.
  • Elicio Therapeutics, Inc. annual Operating Margin for 2022 was -1.03K %, a 643% decline from 2021.
  • Elicio Therapeutics, Inc. annual Operating Margin for 2021 was -139 %, a 92.8% increase from 2020.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q1 2023 -2.61K -2.5K -2183% Jan 1, 2023 Mar 31, 2023
Q4 2022 -1.03K -893 -643% Oct 1, 2022 Dec 31, 2022
Q3 2022 -42 +2.35K +98.2% Jul 1, 2022 Sep 30, 2022
Q2 2022 -73.5 +2.82K +97.5% Apr 1, 2022 Jun 30, 2022
Q1 2022 -114 +2.51K +95.6% Jan 1, 2022 Mar 31, 2022
Q4 2021 -139 +1.78K +92.8% Oct 1, 2021 Dec 31, 2021
Q3 2021 -2.4K Jul 1, 2021 Sep 30, 2021
Q2 2021 -2.9K Apr 1, 2021 Jun 30, 2021
Q1 2021 -2.63K Jan 1, 2021 Mar 31, 2021
Q4 2020 -1.92K Oct 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.